A carregar...

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation

BRAF mutation is one of the important driver oncogene in non‐small‐cell lung cancer (NSCLC). Data on Chinese patients with BRAF‐mutant NSCLC are inadequate. Hence, we conducted this study to investigate the clinicopathologic features and outcomes of Chinese patients with NSCLC and BRAF mutations. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Ding, Xi, Zhang, Zengli, Jiang, Tao, Li, Xuefei, Zhao, Chao, Su, Bo, Zhou, Caicun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345676/
https://ncbi.nlm.nih.gov/pubmed/28135039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!